![](https://financialmodelingprep.com/image-stock/BJDX.png)
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
$935.33K
Mr. Indranil Dey
9.00
Acton, MA
Nov 10, 2021
0.00
$-43.04
3.92
4.38
-648.92%
-0.00
0.00
0.00
0.66
4.38
-86.60%
-187.00%
Similar stocks (9)
IRIDEX Corporation
IRIX
Nexalin Technology, Inc.
NXL
INVO Bioscience, Inc.
INVO
Talis Biomedical Corporation
TLIS
Heart Test Laboratories, Inc.
HSCS
Bone Biologics Corporation
BBLG
Tivic Health Systems, Inc.
TIVC
Nuwellis, Inc.
NUWE
Motus GI Holdings, Inc.
MOTS
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (9)
IRIDEX Corporation
IRIX
Nexalin Technology, Inc.
NXL
INVO Bioscience, Inc.
INVO
Talis Biomedical Corporation
TLIS
Heart Test Laboratories, Inc.
HSCS
Bone Biologics Corporation
BBLG
Tivic Health Systems, Inc.
TIVC
Nuwellis, Inc.
NUWE
Motus GI Holdings, Inc.
MOTS
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%